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ObjectiveaaThe Clinical Research Center for Depression (CRESCEND) study is a 9-year observational collaborative prospective cohort 
study for the clinical outcomes in participants with depressive disorders in Korea. In this study, we examined the baseline characteristics 
of the depressive participants as the hospital-based cohort.
MethodsaaParticipants were assessed using various instruments including the Clinical Global Impression scale, 17-item Hamilton De-
pression Rating Scale (HDRS-17), Hamilton Anxiety Rating Scale, Brief Psychiatric Rating Scale, Social and Occupational Functioning As-
sessment Scale, Beck Depression Inventory-Second Edition, Scale for Suicide Ideation, and World Health Organization Quality of Life as-
sessment instruments-abbreviated version. Also, personal histories of medical and psychiatric illnesses and the range of socio-epidemiolo-
gic and clinical data were collected from each participant. 
ResultsaaOne thousand one hundred eighty three participants were recruited from 18 hospitals. The mean age of the participants was 
47.9±15.9 year-old, 74.4% were female, 82.9% had been diagnosed of major depressive disorder, 40.9% were experiencing their first de-
pressive episode, and 21.4% had a past history of suicide attempts. The majority (85.3%) of the participants were moderately to severely ill. 
The average HDRS-17 was 19.8±6.1. Significant gender differences at baseline were shown in age, education, marriage, employment, re-
ligion, and first depressive episode.
ConclusionaaThe baseline findings in the CRESCEND study showed some different characteristics of depression in Korea, suggesting a 
possibility of ethnic and cultural factors in depression.  Psychiatry Investig 2011;8:1-8
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INTRODUCTION
Depression [especially, major depressive disorder (MDD)] is 
a common psychiatric disorder typically associated with signifi-
cant suffering, high morbidity and mortality rates, and psycho-
social impairment.
1 The 12-month prevalence and the lifetime 
prevalence rates of MDD are estimated at 6.6% and 16.2%, re-
spectively.
2,3 However, considering that depression is often un-
der-recognized and undertreated in the community,
4 the actu-
al prevalence of the depression may be much higher.
Depression is associated with a wide range of negative con-
sequences, including a significant worsening of comorbid me-
dical conditions, a high mortality risk related to suicide, and a 
socioeconomic burden resulting from functional impairment.
5-7 
The magnitude of socioeconomic burden and disability asso-
ciated with depression is increasing. The World Health Organi-
zation (WHO) has reported that by 2020, major depression will 
be second only to ischemic heart disease as a cause of disabili-
ty worldwide. This socioeconomic burden will be even greater 
in the developing countries, where major depression may be the 
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leading cause of disability by 2020.
8,9
Depression is a clinical syndrome having pronounced hetero-
geneity in risk factors, clinical presentation, clinical course, and 
treatment responsiveness.
10 Also its clinical aspects display eth-
nic and cultural variations.
11 To address the many issues depres-
sion presents, a nationwide clinical study, as well as international 
efforts for consensus regarding depression is needed.
In Korea, depression is also a common psychiatric disorder. 
The 12-month prevalence and the lifetime prevalence rates of 
the MDD are 1.7% and 4.3%, respectively.
12 These rates are low-
er than those found in the United States
2,3 and in European coun-
tries,
13 and are similar to those in East-Asian countries.
14-16 The 
reported low prevalence of depression in Korea may reflect the 
fact that there are enormous social stigma attached to depres-
sion, ethnic and cultural influences, and methodological differ-
ences.
11,12,17
Despite the relatively low prevalence of depression, depres-
sion has a deep impact on Korean society. The socioeconomic 
burden of depression in Korea cost over 1.5 billion US dollars 
in 2004.
18 Also, the suicidal rate in Korea is on the increase, up 
to 26.1 persons per 100,000 people in 2005, which was the high-
est position in the Organization for Economic Cooperation and 
Development (OECD) countries.
19 The continuous increase of 
depression itself and suicide, which is one of the serious out-
comes of depression, prompted mental health professionals to 
thoroughly investigate clinical aspects of depression in Korea. 
Unfortunately, up to now, many investigators in Korea have pre-
ferred biological or pharmacological studies to clinical studies 
of depression due to the relatively easy accessibility of the fund-
ing and the fact that there is no long-term prospective clinical 
study for depression with a large cohort in Korea.
The Clinical Research Center for Depression (CRESCEND) 
study is a long-term (phase 1, 1-year; phase 2, 8-year) observa-
tional collaborative prospective cohort study of clinical out-
comes in participants with depressive disorders. The primary 
objective of the CRESCEND study is to investigate the clinical 
risk factors, courses, and outcomes of depression in the Kore-
an society. The secondary objectives include evaluating the 
changes in the quality of life and the risk of suicide according 
to the clinical course of depression, as well as the actual social 
and economic burden of depression, and providing the clinical 
evidence for the development of Korean-specific diagnostic 
tools and clinical practice guidelines. The CRESCEND study is 
the first nationwide long-term observational prospective cohort 
study investigating actual medical care for depressive disorders 
to be conducted in Korea. The aims of this article are to intro-
duce an overview of the CRESCEND study as well as to provide 




From January 2006 to August 2008, 1,183 participants were 
enrolled in the CRESCEND study. The 18 hospitals collaborat-
ing in this study included psychiatric departments of 16 univer-
sity hospitals and 2 general hospitals from all over Korea. Each 
hospital completed a predetermined clinical report form of the 
participants in each visit and recorded the data in the home-
page of the CRESCEND (www.smileagain.or.kr) within 2 days.
The inclusion criteria for the study participants were 1) an 
age over 7 years and 2) a Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV),
20 diagnosis of 
MDD, dysthymic disorder, or depressive disorder, not other 
specified (NOS), as determined by a DSM-IV-based structured 
clinical interview.
21 Exclusion criteria were 1) a current or life-
time comorbid DSM-IV diagnosis of schizophrenia, other psy-
chotic disorders, bipolar disorders, organic psychosis, or demen-
tia, and 2) a current or past history of any significant medical and 
neurological illnesses. 
The consent form and the research protocol were approved 
by the respective university and/or hospital institutional review 
boards. All participants reviewed the informed consent form 
and signed in the presence of research staff before participat-
ing in the study.
Study design
The CRESCEND study included two phases, I and II, with a 
total of 9 follow-up years. The phase I study period was 1 year. 
In phase I, if the eligible participants entered the study at base-
line, each participant visited the hospital and was assessed at 1, 
2, 4, 8, 12, 24, and 52 weeks. The phase II study, an extension 
study from 1 year to 9 years (total 8 years), in which the partici-
pants will be evaluated annually. 
At baseline, the participants underwent a diagnostic evalu-
ation and a retrospective personal history of their medical or 
psychiatric illnesses and treatment. Also, a variety of socio-ep-
idemiologic and clinical data were collected. The clinical, social, 
and functional outcomes associated with the treatment includ-
ing clinician- and self-administered measures were evaluated at 
each visit. 
The clinician-administered measures included the Clinical 
Global Impression scale (CGI),
22 the 17-item Hamilton Depres-
sion Rating Scale (HDRS-17),
23 the Hamilton Anxiety Rating 
Scale (HARS),
24 the Brief Psychiatric Rating Scale (BPRS),
25 
and the Social and Occupational Functioning Assessment Scale 
(SOFAS).
20 
The CGI, which is widely used of extant brief assessment 
tolls in psychiatry, is a 7-point observer-rated scale that meas-
ures illness severity and global improvement or change. The TS Kim et al. 
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HDRS-17 is the most widely used clinical-administered depres-
sion assessment scale. Each item pertains to symptoms of de-
pression experienced over the past week. The HARS is a 14-item 
clinician-administered rating scale and provides an overall 
measure of the severity of global anxiety including psychic and 
somatic symptoms. The BPRS is an 18-item clinician-rated tool 
designed to assess change in severity of psychopathology. The 
items of the BPRS focus on symptoms that are common in psy-
chotic disorder including schizophrenia and other psychotic 
disorders as well as those found in severe mood disorders. The 
SOFAS is a 100-point, single-item scale that rates functioning 
on a hypothetical continuum of mental health to mental illness. 
It focused on the individual’s level of social and occupational 
functioning and is not directly influenced by psychological sy-
mptoms.
The self-administered measures consisted of the Beck De-
pression Inventory-Second Edition (BDI-II),
26 the Scale for Sui-
cide Ideation (SSI),
27 and the World Health Organization Qual-
ity of Life assessment instruments-abbreviated version (WHO-
QOL-BREF).
28 
The BDI-II a 21-item self-report instrument intended to as-
sess the existence and severity of symptoms of depression. It was 
revised in 1996 to be more consistent with DSM-IV criteria for 
depression than the original BDI. The SSI is a 21-item, 3-point 
Likert self-administered scale that asks about suicide ideation 
during the past week. The severity of suicide ideation is calcu-
lated by summing the rating for the first 19 items. The WHO-
QOL-BREF is a 26-item instrument to assess the quality of life, 
which measures the following broad domains: physical health, 
psychological health, social relationships, and environment. It 
is a shorter version of the original WHOQOL that may be more 
convenient for use.
Twice a year, the raters in each individual hospital participat-
ed in formal consensus meetings concerning the use of the rat-
er-administered assessment instruments including the HDRS-
17, the HARS, the BPRS, and the SOPAS. The consensus meet-
ings consisted of an observation of the administration of the 
evaluations by an experienced supervisory psychiatrist and an 
actual administration via videotapes featuring standard MDD 
patients with or without psychotic features. 
Statistical analysis
All data were presented as number (percentage) for categor-
ical variables and as mean (standard deviation) for continuous 
variables. Descriptive statistics were used to characterize the 
study participants at baseline in Table 1 and 2. In Table 3, the 
chi-square test and unpaired t-test were conducted to compare 
the categorical and the continuous variables, respectively, be-
tween men and women. Also, to adjust for the differences in age 
between men and women, multivariate logistic regression and 
analysis of covariance methods were used for the categorical 
and the continuous variables, respectively. The statistical sig-
nificance for all tests was set at p<0.05. All statistical analyses 
were conducted using Statistical Analysis System (SAS), ver-
sion 9.1 (SAS Institute Inc., Cary, NC).
Table 1. Socioepidemiologic characteristics at baselin
Characteristics Values
Age, years
    ≤17 25 (2.1)
    18-29 169 (14.3)
    30-44 269 (22.7)
    45-64 522 (44.1)
    ≥65 198 (16.7)
Sex
    Male 303 (25.6)
    Female 880 (74.4)
Education
    <High school 509 (43.0)
    High school 357 (30.2)
    >Some college 317 (26.8)
Marital status
    Married  780 (65.9)
    Widowed/Separated/Divorced 180 (15.2)
    Never married 223 (18.9)
Living alone
    Yes 141 (11.9)
    No 1,042 (88.1)0.
Brothers and sisters
    Yes 1,101 (93.1)0.
    No 82 (6.9)
Employment
    Employed 424 (35.8)
    Unemployed 759 (64.2)
Annual household income,* US dollars
    <10,000 314 (26.5)
    10,000-30,000 488 (41.3)
    >30,000 381 (32.2)
Religion
    Catholicism 171 (14.5)
    Protestantism 283 (23.9)
    Buddhism 249 (21.0)
    Others 20 (1.7)
    No religion 457 (38.6)
*cutoffs of 10,000 and 30,000 US dollars mean the approximate min-
imum and average costs of a family of 4 members, respectively, in 2006 
in Korea (National Statistics Office, 2007)4  Psychiatry Investig 2011;8:1-8
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RESULTS
Sociodemographic characteristics
A total of 1,183 participants with depression were enrolled 
in this study. The sociodemographic characteristics of the par-
ticipants at baseline are shown in Table 1. The mean±standard 
deviation of age and education levels in all participants were 
47.9±15.9 year-old and 10.4±4.5 years, respectively. The age 
ranged between 11 and 83 years old. Fifty-nine participants 
(5.0%) were not educated at all. Overall, more women (74.4%) 
than men participated in the study. Among the 780 married par-
ticipants, only 12 persons (1.5%) had remarried. Fifty-nine per-
sons (6.1%) had no children among 960 participants who had 
been married. Nine hundred eighty-one participants (82.9%) 
had a diagnosis of MDD according to the DSM-IV criteria, 
among which only 24 persons had psychotic features at base-
line. The participants who were diagnosed with dysthymic dis-
order or depressive disorder, NOS at baseline, were 38 (3.2%) 
and 164 (13.9%) persons, respectively.
Clinical characteristics
The clinical characteristics of the participants at baseline 
were summarized in Table 2. At baseline, most of the partici-
pants (83.8%) took one or more antidepressant medications. 
Forty-eight participants (4.1%) had 5 or more depressive epi-
sodes. The youngest and oldest ages of onset of the first depres-
sive episode were 10 and 83 years old, respectively. The most fre-
quent medical comorbidity was hypertension (178 persons, 
15.0%). In the participants who had a past history of suicide at-
tempts (253 persons, 21.4%), the mean±standard deviation 
number of suicide attempts and age at first suicide attempt were 
2.1±2.7 and 31.0±13.8 year-old, respectively. Two hundred eigh-
ty participants (23.7%) had experienced adverse life events be-
fore the age of twelve, such as the death of the siblings and par-
ents, sexual or physical abuse, the separation/divorce or econo-
mic crisis of the parents, natural disaster, and bullying.
Overall, the participants were moderately to severely ill (1,009 
persons, 85.3%), based on CGI-severity. Only 29 depressive 
participants (2.5%) were in the remission state (HDRS-17 ≤7) at 
baseline. The mean±standard deviation scores of CGI-severi-
ty in MDD, dysthymic disorder and depressive disorder NOS 
were 4.7±1.0, 3.8±1.0, and 4.4±1.0, respectively. Also, the mean± 
standard deviation scores of HRDS-17 among the three groups 
were 20.2±6.0, 16.5±5.7, and 18.2±6.0, respectively.
Gender differences
Table 3 summarized gender differences with respect to the 
socioepidemiologic and clinical characteristics of the depressive 
participants at baseline. The mean age for women (48.8 years) 
was higher than that for men (45.5 years)(unadjusted p<0.0001). 
The gender groups differed in terms of education group (p< 
0.0001, adjusted for age). Women had fewer years of education 
(9.9 years) than men (11.9 years)(p<0.0001, adjusted for age). 
There was a significant gender difference in marital status (p< 
0.0001, adjusted for age). Widowed, separated, or divorced wom-
en were more than 7 times as prevalent in this sample as men hav-
ing the same status. Employment status differed by gender (p< 
0.0001, adjusted for age). Among the unemployed women, 466 
women (74.4%) were housewives. There was a significant differ-
ence in religion status by gender (p=0.025, adjusted for age): more 
men (48.9%) than women (35.1%) indicated a lack of religious 
beliefs. 
The proportion of women (78.4%) and men (78.2%) who were 
recruited from the outpatient setting were similar. Women who 
Table 2. Clinical characteristics at baseline
Characteristics Values
Current setting
    Inpatient 256 (21.6)
    Outpatient 927 (78.4)
First depressive episode
    Yes 484 (40.9)
    No 674 (67.0)
Age at onset of 1st depressive episode, years 44.9 (17.0)
Number of depressive episodes 1.8 (1.8)
Current general medical comorbidities
    Yes 386 (32.6)
    No 797 (67.4)
Past history of suicide attempt
    Yes 253 (21.4)
    No 930 (78.6)
Family history of depression
    Yes 163 (13.8)
    No 995 (84.1)
Scores of psychiatric measures
HDRS-17 19.8 (6.1) 0
BDI-II 29.1 (11.7).
HARS 18.8 (8.5) 0




HDRS-17: 17-item Hamilton Depression Rating Scale, BDI-II: Beck 
Depression Inventory-Second Edition, HARS: Hamilton Anxiety 
Rating Scale, SSI: Scale for Suicide Ideation, CGI-S: Clinical Global 
Impression scale–Severity, SOFAS: Social and Occupational Func-
tioning Assessment Scale, WHOQOL-BREF: World Health Orga-
nization Quality of Life assessment instruments-abbreviated version TS Kim et al. 
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Table 3. Gender differences of the baseline characteristics
Characteristics N Men (N=303) Women (N=880) Unadjusted p-value Adjusted p-value*
Age, years 1,183 <0.0001 -
    ≤17 9 (3.0) 16 (1.8)
    18-29  68 (22.4) 101 (11.5)
    30-44 61 (20.1) 208 (23.6)
    45-64 110 (36.3)0 412 (46.8)
    ≥65 55 (18.2) 143 (16.3)
Education 1,183 <0.0001 <0.0001
    < High school  90 (29.7) 419 (47.6)
    High school 99 (32.7) 258 (29.3)
    > Some college 114 (37.6)0 203 (23.1)
Marital status 1,183 <0.0001 <0.0001
    Married  175 (57.8)0 605 (68.8)
    Widowed/Separated/Divorced 25 (8.3)0 155 (17.6)
    Never married 103 (34.0)0 120 (13.6)
Living alone 1,183 0.355 0.351
    Yes 31 (10.2) 110 (12.5)
    No 272 (89.8)0 770 (87.5)
Brothers and sisters 1,183 0.681 0.818
    Yes 283 (93.4)0 827 (94.0)
    No 20 (6.6)0 53 (6.0)
Employment 1,183 <0.0001 <0.0001
    Employed 170 (56.1)0 254 (28.9)
    Unemployed 133 (43.9)0 626 (71.1)
Annual household income, US dollars 1,183 0.726 0.109
    <10,000 85 (28.1) 229 (26.0)
    10,000-30,000 125 (41.3)0 363 (41.3)
    >30,000 93 (30.7) 288 (32.7)
Religion 1,180 0.001  0.025
    Catholicism 35 (11.6) 136 (15.5)
    Protestantism 65 (21.5) 218 (24.8)
    Buddhism 52 (17.2) 198 (22.5)
    Others 2 (0.7) 17 (1.9)
    No religion 148 (48.9)0 309 (35.1)
Current setting 1,183 0.936 0.821
    Inpatient 66 (21.8) 190 (21.6)
    Outpatient 237 (78.2)0 690 (78.4)
First depressive episode 1,158 0.048 0.453
    Yes 109 (36.8)0 375 (43.5)
    No 187 (63.2)0 487 (56.5)
Age at onset of 1st depressive episode, years 1,183 43.1 (18.9)0. 44.8 (16.3). 0.159 0.016
Number of depressive episodes 1,183 1.7 (1.9)0. 1.8 (1.7). 0.478 0.557
Current general medical comorbidities 1,183 0.887 0.180
    Yes 100 (33.0)0 286 (32.5)
    No 203 (67.0)0 594 (67.5)6  Psychiatry Investig 2011;8:1-8
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had experienced their first depressive episode at baseline were 
more prevalent in this sample than men, but it was not signif-
icantly different after adjusting for age (p=0.453). Men had a so-
mewhat earlier onset of their first depressive episode (mean of 
43.1 years) than women (mean of 44.8 years, p= 0.016, adjusted 
for age). The proportions of women and men with respect to the 
number of depressive episodes and the presences of current gen-
eral medical comorbidities, past history of suicide attempts, and 
family history of depression were similar. Also, mean scores of in-
dividual psychiatric measures at baseline did not differ by gen-
der in this study. 
DISCUSSION
The CRESCEND study is the first long-term prospective col-
laborative observational cohort study investigating the natural 
course and outcome of depressive patients to be conducted in 
Korea. The participants were enrolled in 18 hospitals from all 
over Korea and the distribution of participated hospitals reflect-
ed the spread of population in Korea. Though a number of nat-
uralistic cohort studies of depression have been conducted all 
over the world (especially in the Western world), there are still 
numerous questions about the clinical and socioeconomic out-
comes resulting from actual clinical and medical practices for 
depression; the results of those studies are difficult to extend to 
Eastern societies given broad ethnic and cultural differences. 
The CRESCEND study was designed to investigate the more 
long-term comprehensive outcomes of depression in order to 
overcome the limitations stated above. In this report we have 
described the research methodology of the CRESCEND study 
and reported the baseline findings from the depressive samples. 
Some interesting baseline findings were found in the CRE-
SCEND study.
Though the age distribution of this study was statistically nor-
mal, the child and adolescent depressive participants (≤17 year-
old) were very few (2.1%), but the proportion of geriatric depres-
sive participants (≥65 year-old) was relatively high (16.7%). 
This finding may be an artifact of methodological problems for 
specific age groups such as parental reluctance to permit chil-
dren to participate in the study and indirectly, reflection of re-
cent lower birth rate and more increased aged population in 
Korea. The female prevalence in this study was 74.4%. The gen-
der ratio of 2.9 seen in women vs. men willing to enroll in this 
study is higher than that of several previous reports,
2,29,30 but 
similar to that reported in the Korean Epidemiologic Catchment 
Area study.
12 Though a higher female prevalence in depression 
study may indicate that women have greater tendency to seek 
treatment, or greater willingness to participate in the study,
29 this 
finding may be influenced by the actual gender prevalence of de-
pression in Korea. However, the ethnic or cultural differences of 
a heightened stigma of depression among men could be also 
considered.
11 
Several distinctive clinical findings of depression at baseline 
were revealed in the CRESCEND study. First, the mean age at 
onset of the first depressive episode in this study was 44.9 years 
old, which is higher than that of previous studies.
31-33 Textbooks 
typically suggest a mean age of onset for depression of about 40 
years. Considering that the mean age of enrolled participants 
Table 3. Continued
Characteristics N Men (N=303) Women (N=880) Unadjusted p-value Adjusted p-value*
Past history of suicide attempt 1,183 0.745 0.583
    Yes 67 (22.1) 186 (21.1)
    No 236 (77.9)0 694 (78.9)
Family history of depression 1,158 0.846 0.770
    Yes 40 (13.5) 123 (14.3)
    No 256 (86.5)0 739 (85.7)
Scores of psychiatric measures
HDRS-17 1,183 19.8 (6.3)00. 19.8 (6.0).0 0.877 0.476
BDI-II 1,037 29.1 (12.3)0. 29.1 (11.5). 0.994 0.729
HARS 1,183 18.5 (8.8)00. 18.9 (8.5).0 0.516 0.919
SSI 0.990 11.5 (9.3)00. 10.4 (8.6).0 0.089 0.412
CGI-S 1,183 4.6 (1.1)0. 4.6 (1.0). 0.281 0.592
SOFAS 1,152 57.6 (12.0)0. 59.0 (10.8). 0.075 0.034
WHOQOL-BREF 0.998 63.9 (11.3)0. 64.0 (10.1). 0.866 0.882
*adjusted for age. HDRS-17: 17-item Hamilton Depression Rating Scale, BDI-II: Beck Depression Inventory-Second Edition, HARS: Hamil-
ton Anxiety Rating Scale, SSI: Scale for Suicide Ideation, CGI-S: Clinical Global Impression scale–Severity, SOFAS: Social and Occupational 
Functioning Assessment Scale, WHOQOL-BREF: World Health Organization Quality of Life assessment instruments-abbreviated versionTS Kim et al. 
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was 47.9, which is also higher, compared to the previous stud-
ies, this finding may reflect a fact of depression in Korea. How-
ever, problems of the participants related to inadequate infor-
mation and the social stigma about depression in the Korean 
society should not be overlooked. Second, among 1,183 depres-
sive participants, 21.6% had a past history of one or more self-
reported suicide attempts. This is higher than the prevalence 
of 16.5% found in the Sequenced Treatment Alternatives to 
Relieve Depression (STAR*D) study.
34 The difference at base-
line in the history of suicide attempts between the two studies 
may be mainly due to sampling procedures and settings, but it 
should be emphasized that Koreans have the highest rate of sui-
cide among OECD countries. Thirdly, the prevalence of a fam-
ily history of depression in this study was only 13.8%, which is 
lower than that of the previous studies.
35,36 The family history 
of depression is an important factor for predicting the likeli-
hood of a person having depression as well as the severity and 
outcome of depression.
37 Some possible explanations of this find-
ing may be 1) no use of a structured interview form to determine 
family history of depression, 2) lack of reliable information of 
depression in the participants’ family, and 3) unwillingness to 
expose the history of familial depression due to the cultural stig-
ma of depression.
In these baseline results, some gender differences noted among 
the depressive participants in socioepidemiologic data (e.g., high-
er education level in males, higher employment in males, and 
higher religion-seeking tendency in females) may be influenced 
in part by cultural gender differences in current Korean society. 
These findings were inconsistent compared to Western coun-
tries.
29,38 Interestingly, no gender difference adjusted for age in 
past history of suicide attempts was found in this study. One of 
the most consistent research findings in the literature on sui-
cide is that men have higher suicide rates than women, even th-
ough women make more suicide attempts than men.
39 In Ko-
rea, one person every 90 seconds attempted suicide regardless 
of actual suicide success in 2003.
40 This finding reflects the rel-
ative increase of suicide attempts in Korean depressive men, 
which might be related to increased psychosocial stress in men 
directly influenced by the recent economic crisis in Korea.
41
This study has several limitations. While the cross-sectional 
observational methodology is useful for the better understand-
ing of real-life clinical practice, there are limitations on the caus-
al inferences that can be drawn due to uncontrollable confound-
ing factors, selection bias, and reverse causality. Though the 
results of this study were cross-sectional and observational, the 
CRESCEND study itself was designed as a prospective cohort 
study. Thus, further analyses of the longitudinal data may over-
come several limitations. In this study, nearly three-fourths of 
participants with depression were enrolled from outpatient set-
tings. This fact may have resulted in a selection bias that influ-
enced findings of symptom severity, the presence of psychotic 
symptoms, and the frequency of subtypes of depression includ-
ing dysthymic disorder and depressive disorder NOS. Only 
2.0 percent of depressive participants, all of whom were enrolled 
from the inpatient setting, had psychotic features. However, the 
differences in depressive symptom severity at baseline between 
inpatients and outpatients were not significant in this study. 
The CRESCEND study is the first long-term hospital-based 
prospective collaborative observational cohort study investigat-
ing the in situ course and outcome of depressive participants to 
be conducted in Korea. In this cohort study, we will investigate 
the Korean-specific characteristics of depression including psy-
chopathology, risk factors, clinical courses, and prognosis and 
establish the clinical evidences to develop the clinical practice 
guidelines for depression in the Korean society. A series of the 
results from the CRESCEND study will provide valuable infor-
mation about real-life clinical practices for depression in Korea 
as well as the ethnic and cultural differences in depression be-
tween the East and the West.
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